0001140361-15-025490.txt : 20150626 0001140361-15-025490.hdr.sgml : 20150626 20150626083033 ACCESSION NUMBER: 0001140361-15-025490 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150625 FILED AS OF DATE: 20150626 DATE AS OF CHANGE: 20150626 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Asterias Biotherapeutics, Inc. CENTRAL INDEX KEY: 0001572552 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 461047971 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 230 CONSTITUTION DRIVE CITY: MENLO PARK STATE: CA ZIP: 94025 BUSINESS PHONE: 510-521-3390 MAIL ADDRESS: STREET 1: 230 CONSTITUTION DRIVE CITY: MENLO PARK STATE: CA ZIP: 94025 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LeBuhn Richard T. CENTRAL INDEX KEY: 0001428664 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36646 FILM NUMBER: 15953379 MAIL ADDRESS: STREET 1: 25541 COMMERCENTRE DR. CITY: LAKE FOREST STATE: CA ZIP: 92630-8870 4 1 doc1.xml FORM 4 X0306 4 2015-06-25 0 0001572552 Asterias Biotherapeutics, Inc. AST 0001428664 LeBuhn Richard T. 724 FIFTH AVENUE, 9TH FLOOR NEW YORK NY 10019 1 0 0 0 Series A Common Stock 2015-06-25 4 P 0 5000 4.4124 A 5000 D The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.3899 to $4.42 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased by him at each separate price on each date of sale. /s/ Richard T. LeBuhn 2015-06-25